Sero-epidemiology of mumps in western Europe

被引:29
作者
Nardone, A
Pebody, RG
Van den Hof, S
Levy-Bruhl, D
Plesner, AM
Rota, MC
Tischer, A
Andrews, N
Berbers, G
Crovari, P
Edmunds, WJ
Gabutti, G
Saliou, P
Miller, E
机构
[1] Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England
[2] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands
[3] Inst Veille Sanitaire, Paris, France
[4] Statens Serum Inst, DK-2300 Copenhagen, Denmark
[5] Ist Super Sanita, I-00161 Rome, Italy
[6] Robert Koch Inst, D-1000 Berlin, Germany
[7] Univ Genoa, Fac Med, Sect Hyg & Prevent Med, Dept Hlth Sci, Genoa, Italy
[8] Univ Lecce, Fac Sci, Dept Biol & Environm Sci & Technol, Hyg Lab, I-73100 Lecce, Italy
[9] Aventis Pasteur, Paris, France
关键词
D O I
10.1017/S0950268803008768
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Six countries (Denmark, England and Wales, France, Germany, Italy and the Netherlands) conducted large serological surveys for mumps, in the mid-1990s, as part of the European Sero-Epidemiology Network (ESEN). The assay results were standardized and related to the schedules and coverage of the immunization programmes and the reported incidence of mumps. Low incidence of disease and few susceptibles amongst adolescents and young adults was observed in countries with high mumps vaccine coverage (e.g. the Netherlands). High disease incidence and large proportions of mumps virus antibody negative samples in adolescent and young adult age groups was noted in countries with poor vaccine coverage (e.g. Italy). The build-up of susceptibles in older children and adolescents in England and Wales, France, the former West Germany and Italy indicate the possibility of further mumps outbreaks in secondary school environments. To control mumps in western Europe, current MMR immunization programmes will need to be strengthened in a number of countries. Sero-surveillance of mumps is an important component of disease control and its usefulness will be enhanced by the development of an international mumps standard.
引用
收藏
页码:691 / 701
页数:11
相关论文
共 34 条
[1]   THE EPIDEMIOLOGY OF MUMPS IN THE UK - A PRELIMINARY-STUDY OF VIRUS TRANSMISSION, HERD-IMMUNITY AND THE POTENTIAL IMPACT OF IMMUNIZATION [J].
ANDERSON, RM ;
CROMBIE, JA ;
GRENFELL, BT .
EPIDEMIOLOGY AND INFECTION, 1987, 99 (01) :65-84
[2]   The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella [J].
Andrews, N ;
Pebody, RG ;
Berbers, G ;
Blondeau, C ;
Crovari, P ;
Davidkin, I ;
Farrington, P ;
Fievet-Groyne, F ;
Gabutti, G ;
Gerike, E ;
Giordano, C ;
Hesketh, L ;
Marzec, T ;
Morgan-Capner, P ;
Osborne, K ;
Pleisner, AM ;
Raux, M ;
Tischer, A ;
Ruden, U ;
Valle, M ;
Miller, E .
EPIDEMIOLOGY AND INFECTION, 2000, 125 (01) :127-141
[3]  
[Anonymous], 1994, Bull World Health Organ, V72, P885
[4]   SUSTAINED TRANSMISSION OF MUMPS IN A HIGHLY VACCINATED POPULATION - ASSESSMENT OF PRIMARY VACCINE FAILURE AND WANING VACCINE-INDUCED IMMUNITY [J].
BRISS, PA ;
FEHRS, LJ ;
PARKER, RA ;
WRIGHT, PF ;
SANNELLA, EC ;
HUTCHESON, RH ;
SCHAFFNER, W .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (01) :77-82
[5]  
Chamot E, 1998, REV EPIDEMIOL SANTE, V46, P100
[6]   Monitoring the compliance of sentinel general practitioners in public health surveillance: Which GPs persevere? [J].
Chauvin, P ;
Valleron, AJ .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1997, 26 (01) :166-172
[7]  
Childs James E., 1993, Morbidity and Mortality Weekly Report, V42, P1
[8]   METHODS FOR SCREENING THE NATURALLY ACQUIRED AND VACCINE-INDUCED IMMUNITY TO THE MUMPS-VIRUS [J].
CHRISTENSON, B ;
BOTTIGER, M .
BIOLOGICALS, 1990, 18 (03) :213-219
[9]   PERSISTENCE OF ANTI-MUMPS VIRUS-ANTIBODIES AFTER A 2 DOSE MMR VACCINATION - A 9-YEAR FOLLOW-UP [J].
DAVIDKIN, I ;
VALLE, M ;
JULKUNEN, I .
VACCINE, 1995, 13 (16) :1617-1622
[10]  
Dias J.A., 1996, Euro Surveill, V1, P25